Jul
6
2023
On demand
Overcoming challenges in scaled manufacturing of iPSC-derived cells
Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
This webinar will delve into the challenges of translating workflows into a GMP-compliant environment, specifically focusing on regenerative medicine in cardiovascular diseases. Discussion will focus on the pre-clinical development path, and hurdles related to raw materials supply chain management, and identifying equipment compatible with the execution of novel, compliant manufacturing processes.
Learn how the MACSQuant® Tyto®, with its closed and sterile cell sorting system, is the ideal solution for easily translating workflows from the research bench to clinical manufacturing.
Attend this webinar to learn about:
- How to ease the translation of flow sorting from RUO to GMP compliance using the MACSQuant Tyto
- Considerations for developing a process to achieve target final cell product purity
- Benefits and challenges of working in a quality system during early-stage process development
SPEAKERS
You might also like
Achieving cost effective, scalable high-titer AAV production
Chao Yan Liu, Christine Le Bec
24 August
in 111
Days
Hit the lentiviral characterization jackpot with accurate RNA detection
Bhargavi Kondragunta
14 April
Watch
Mastering allogeneic NK cell therapies: flexibility, robustness, and speed to clinic
Jane Lebkowski
31 March
Watch
Biological & operational considerations for iPSC-derived cell production
Austin Mogen
24 March
Watch
Closing the gap: Modelling benefits of AAV scale-up using novel enhancers
Austin Mogen
12 March
Watch